Literature DB >> 29115489

Isorhamnetin prevents H2O2‑induced oxidative stress in human retinal pigment epithelial cells.

Jing Wang1, Hui-Min Gong2, Hui-Hui Zou3, Ling Liang3, Xin-Yi Wu1.   

Abstract

Isorhamnetin, a 3‑O‑methylated metabolite of quercetin, exhibits antioxidant effects. However, to the best of our knowledge, no study to date has focused on the effects of isorhamnetin on retinal pigment epithelium (RPE) cells, and its underlying molecular mechanisms. Therefore, the present study aimed to examine the potential protective effect of isorhamnetin against oxidative stress in human RPE cells. The results demonstrated that pretreatment of RPE cells with isorhamnetin significantly protected cell viability against oxidative stress. In addition, isorhamnetin pretreatment inhibited hydrogen peroxide (H2O2)‑induced reactive oxygen species (ROS) production and caspase‑3 activation in RPE cells. Furthermore, isorhamnetin pretreatment significantly increased the phosphorylation of phosphoinositide 3‑kinase (PI3K) and AKT serine/threonine kinase 1 (Akt) in RPE cells exposed to H2O2, compared with cells treated with H2O2 alone. Taken together, the present results demonstrated that isorhamnetin protected human RPE cells from oxidative stress‑induced cell death, and this effect was associated with activation of the PI3K/Akt signaling pathway. Thus, isorhamnetin may be considered as a potential antioxidant useful for the prevention of age‑related macular degeneration.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29115489     DOI: 10.3892/mmr.2017.7916

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  8 in total

1.  Evaluation of Antioxidative and Neuroprotective Activities of Total Flavonoids From Sea Buckthorn (Hippophae rhamnoides L.).

Authors:  Zheng Wang; Wenqian Wang; Changlong Zhu; Xiangdong Gao; Weihua Chu
Journal:  Front Nutr       Date:  2022-06-21

2.  Exploring the Mechanism of Action Compound-Xueshuantong Capsule in Diabetic Retinopathy Treatment Based on Network Pharmacology.

Authors:  Haoran Li; Biao Li; Yanlin Zheng
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-09       Impact factor: 2.629

3.  Rhizoma Paridis total saponins alleviate H2O2‑induced oxidative stress injury by upregulating the Nrf2 pathway.

Authors:  Baocheng Zhao; Zhenjun Wang; Jiagang Han; Guanghui Wei; Bingqiang Yi; Zhulin Li
Journal:  Mol Med Rep       Date:  2019-11-20       Impact factor: 2.952

4.  Isorhamnetin Ameliorates Aspergillus fumigatus Keratitis by Reducing Fungal Load, Inhibiting Pattern-Recognition Receptors and Inflammatory Cytokines.

Authors:  Xue Tian; Xudong Peng; Jing Lin; Yingxue Zhang; Lu Zhan; Jiao Yin; Ranran Zhang; Guiqiu Zhao
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-03-01       Impact factor: 4.799

5.  Antioxidant and Inflammatory Effects of Nelumbo nucifera Gaertn. Leaves.

Authors:  Chong Li; Yongpeng He; Yue Yang; Yuting Gou; Shuting Li; Rui Wang; Shi Zeng; Xin Zhao
Journal:  Oxid Med Cell Longev       Date:  2021-12-28       Impact factor: 6.543

6.  Isorhamnetin Alleviates Airway Inflammation by Regulating the Nrf2/Keap1 Pathway in a Mouse Model of COPD.

Authors:  Yifan Xu; Jing Li; Zhiwei Lin; Weiquan Liang; Lijie Qin; Jiabin Ding; Shuqi Chen; Luqian Zhou
Journal:  Front Pharmacol       Date:  2022-03-24       Impact factor: 5.810

7.  Isorhamnetin alleviates lipopolysaccharide-induced inflammatory responses in BV2 microglia by inactivating NF-κB, blocking the TLR4 pathway and reducing ROS generation.

Authors:  Shin Young Kim; Cheng-Yun Jin; Cheol Hong Kim; Young Hyun Yoo; Sung Hyun Choi; Gi-Young Kim; Hyun Min Yoon; Hwan Tae Park; Yung Hyun Choi
Journal:  Int J Mol Med       Date:  2018-11-20       Impact factor: 4.101

8.  Tribulus terrestris Ameliorates Oxidative Stress-Induced ARPE-19 Cell Injury through the PI3K/Akt-Nrf2 Signaling Pathway.

Authors:  Zhenli Yuan; Weiwei Du; Xiangdong He; Donglei Zhang; Wei He
Journal:  Oxid Med Cell Longev       Date:  2020-07-28       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.